welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

key information

study id #: NCT02295748

condition: Duchenne Muscular Dystrophy

status: completed


This is an open label, long-term extension study in approximately 24 male DMD subjects consisting of children (ages 4-12, inclusive) and adolescents (ages 13-16, inclusive) who participated in the MP-104-CL-005 PK study.

intervention: Deflazacort

mechanism of action: Glucocorticoid to delay decline in muscle strength

results: https://clinicaltrials.gov/ct2/show/results/NCT02295748

last updated: November 22, 2018